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Specifically sensitized lymphoid cells and,  in certain cases, circulating anti- 
bodies have been shown to play a major role in the immunological rejection of 
homografts (1, 2). However, the mechanisms by which sensitized lymphoid cells 
reject foreign grafted tissue is still largely unknown. The introduction of tissue 
culture systems (3-8) has allowed a better understanding  and characterization 
of the  rejection and  destruction  of allografts. It has been demonstrated  that 
lymphoid cells from an animal that had undergone graft rejection were subse- 
quently capable in vitro of specifically destroying target cells of the same strain 
as the  graft donor.  Brondz  and his  colleagues  (9,  10)  have demonstrated  the 
possibility of depleting a lymphoid cell population of cells that are active in  the 
in vitro lysis of target cells by incubating sensitized lymphoid  cells  on specific 
macrophage monolayers. 
This report presents the results of a series of experiments which  demonstrate 
that  in  vitro  absorption  of  mouse  spleen  cells  sensitized  against  allogeneic 
tumors onto fibroblast monolayers specifically depletes the immunoreactive cell 
population.  Furthermore,  the  immunoreactive  cells  can  subsequently  be  re- 
covered from the  fibroblast monolayers and  are  reactive in  in  vitro  lysis of 
tumor cells and in vivo retardation of tumor growth. 
The  results  indicate  that  the  population  of l?Tnphoid  ceils reactive in  the 
rejection of tumor  allografts in  vivo is  the  same as  that  involved in  the  de- 
struction of tumor cells in vitro. 
Materials and Methods 
Anlmals.--Mice of the following strains were used: DBA/2J  (H-2  d) females, A/J (H-2'*) 
females, BALB/cJ  (H-2  d) males, C57BL/6J  (//-2  b) males and  females, and  (C57BL/6J M 
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A/J)F1 hybrid females (B6AF1). 1 Animals were 3-6 months old when used. Sources of embryos 
for preparation of fibroblast monolayers were pregnant mice on days 14-17 of gestation. All 
animals were purchased from the Jackson Laboratory, Bar Harbor, Maine. 
Tumors.--Spindle cell sarcoma (SaI) of A/J was obtained from the Jackson Laboratory as 
a subcutaneous tumor and was carried in the ascites form by weekly transfer of 5 X  106 tumor 
cells into A/J females. EIA leukosis of C57BL/6 (EIA) was obtained from Dr. John Wunder- 
lich, National Cancer Institute, Bethesda, Md., and was carried as an ascites tumor by weekly 
transfer of 3  ×  10  ~ tumor cells in C57BL/6J males. P815  mastocytoma of  DBA/2  (P815) 
was obtained from Dr. M. Potter, National Cancer Institute, and was carried in an ascites 
form by weekly injection of 1 ×  108 tumor cells in DBA/2J females. 
Immunization  of  Mice  against  Tumors.--Animals  were  immunized  against  allogeneic 
tumors by intraperitoneal injection of 3  X  l0  T tumor cells which had been washed in phos- 
phate-buffered saline (PBS). 
Preparation  o.f Spleen  Cell Suspensions.--Animals were killed 10-11 days after immuniza- 
tion and the spleens were removed under sterile conditions and placed in cold PBS containing 
10% heat-inactivated fetal calf serum (PBS-FCS). The spleens were minced, pressed through 
fine nylon mesh, filtered through gauze, and centrifuged in the cold at 250 g for 10 rain. The 
pellet was resuspended in PBS-FCS and the cells were centrifuged again. Nucleated cells were 
counted and the number of dead cells was determined by eosin dye exclusion. Spleen cells 
prepared as above and kept on ice did not lose reactivity for at least 4 hr when tested in the 
systems described below. 
In  Vitro Assessment  of Lysis of Tumor Cells.--The assessment of lysis of tumor cells was 
done as previously described (4,  11,  12), with the following modifications. Tumor cells were 
collected in PBS-FCS via syringe from the peritoneal cavity, and 3  X  l0  T washed cells were 
labeled with 100 gCi (51Cr)  Na2CrO4 (Amersham/Searle Corp.,  Arlington Heights, Ill.) in 1 
ml of PBS-FCS for 45 rain at 37°C with occasional shaking. At the end of the labeling period, 
cells were washed twice with 40 ml of PBS-FCS and then were recounted.  Usually,  80-90% 
of the labeled cells were recovered. 5 )< 104 SlCr-labeled tumor cells and 5 )< l0 s spleen cells 
in MEM-FCS  (Eagle's minimal essential medium containing 100 units of penicillin and 100 
/zg  of  streptomycin/ml,  supplemented with  10%  heat-inactivated fetal calf  serum)2 were 
plated in 1 ml volumes in 35-mm plastic Petri dishes (Falcon Plastics, Division B-D Labora- 
tories, Inc., Los Angeles, Calif.). The plates were rocked on a  rocker platform (Bellco Glass, 
Inc., Vineland, N.  J.)  at 5 rocks/min at 37°C  in a  humidified incubator gassed with 10% 
CO2 in air. To determine the amount of released radioactivity, 1 ml of cold PBS-FCS was 
added to  the plates and the suspensions were transferred to small plastic tubes. The tubes 
were centrifuged in the cold at 1000 g for 10 min, and the radioactivity in the supernatant 
was assayed using a well-type gamma scintillation counter. To assay the maximum amounts 
of releasable radioactivity, labeled tumor ceils were frozen and thawed three times, centri- 
fuged,  and  the radioactivity of  the supernatant assayed.  This represented 90-95%  of  the 
radioactivity that was incorporated into the labeled cells. 
Four, and in a few cases two, replicate cultures were used for the assessment of the lysis 
of tumor cells; the relative standard deviation from the mean of the amount of released radio- 
activity was below 3%. 
1 Abbreviations used in this  paper:  B6AF1,  (C57BL/6J  X  A/J)F1 ; BSA,  bovine serum 
albumin; EL4,  EL4 leukosis of  C57BL/6J;  MEM-FCS,  Eagle's minimal essential medium 
supplemented with 10~o heat-inactivated fetal calf serum; P815, P815 mastocytoma of DBA/ 
2J; PBS, phosphate-buffered saline; PBS-FCS, phosphate-buffered saline supplemented with 
10% heat-inactivated fetal call serum; SaI, spindle cell sarcoma of A/J mice. 
2 Tissue  culture  media  and  supplements  were  obtained  from  Grand  Island  Biological 
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Results  were expressed as per cent lysis calculated  with the following equation  (11,  12): 
Per cent lysis  = 
(cpm released by immune s,)leen cells)  --  (cpm released by normal  spleen  cells) 
cpm released by freeze thawed tumor cells 
X  100. 
Embryo  Fibroblast  Monolayers.--Mouse  primary  fibroblast  cultures were  prepared  using 
14-17-day-old embryos by a  technique which has been described in detail elsewhere (13). In 
brief, primary fibroblast monolayers were cultured in MEM-FCS; these were trypsinized and 
transferred  to  secondary cultures  every 7-12  days.  Only  confluent secondary culture  were 
used for the absorption experiments. Human fibroblasts that were cultured from fetal tissue 
were also used. 
Absorption  of Spleen  Cells on Fibroblast Monolayers.--Confluent  fibroblast monotayers in 
100-ram plastic Petri dishes (Falcon Plastics) containing 7-12 million fibroblasts per dish were 
used for absorption of the spleen cells. 60 X  108 spleen cells in 5 ml of MEM-FCS were plated 
per dish and  the cultures were incubated at 37°C for 3-4 hr with occasional shaking. At the 
end  of this  absorption period,  the plates were rotated for 3  rain at  50  rotations/min  on a 
mechanical rotator  (Arthur H.  Thomas  Co.,  Philadelphia, Pa.)  and  the fluid phase was re- 
moved and  diluted  with cold PBS-FCS.  The  number  of nucleated  cells was redetermined; 
usually,  50-70%  of the nucleated cells was recovered; the cells were assayed in an  in  vitro 
tumor cytotoxicity assay or in an in vivo tumor neutralization test. 
The  calculation  of per  cent decrease in  lysis  of  target  cells  obtained  in  the  absorption 
experiments was done as follows: 
Per cent decrease in lysis  = 
Per cent lysis with spleen cells  (Per cent lysis with spleen cells incubated'~ 
incubated in empty plates  /  --  \on  fibroblast monolayers  ] 
per cent lysis with spleen cells incubated in empty plates 
X  100. 
Fractlonation  of Cells on  Albumin  Density  Gradient  (14).--Cells  were suspended in  17% 
bovine serum albumin (BSA) and placed on top of a  discontinuous BSA gradient and separ- 
ated  by centrifugation at  1000  g  for 30  nfin at  4°C.  BSA fraction V  (Sigma Chemical Co., 
St.  Louis,  Mo.),  35%  (refractive  index  determination)  and  320  mOs~  (by  freezing point 
depression), was used for fractionation. After dilution with PBS, 1 ml of 32%  albumin solu- 
tion was placed at the bottom of plastic tubes; on top of this was layered sequentially 1 ml 
of 25% and 1 ml of 20% BSA. Cells were recovered from the gradient interfaces with a Pasteur 
pipette,  washed  twice in  an  excess of  MEM-FCS,  counted  differentially,  and  assayed  for 
reactivity. 
Tumor  Neutralization  Assay.--Winn's  assay  (15)  with  some  modifications was  used.  A 
mixture of tumor cells and spleen cells was prepared in cold PBS, and 0.05 ml of this suspen- 
sion was injected subcutaneously into the shaved abdominal wall of  (C57BL/6J  X  A/J)FI 
female mice. 
The growth of the tumors was measured with calipers at intervals of 1-5 days. Two dif- 
ferent diameters were recorded for each tumor at the time of observation. The average geo- 
metric  mean was  calculated  by  division of  the  sum  of the  mean  tumor  diameters  by  the 
number of animals measured. Mortality of animals was also recorded. GIDEON  BERKE  AND  RAPHAEL  H.  LEVEY  975 
RESULTS 
Cytolytic  Effects  of Immune  and  Normal  Spleen  Cells  on  Tumor  Cells  In 
Vitro.--The cytolytic effects on  target tumor cells of spleen cells sensitized by 
tumor homografts and of normal spleen  cells were studied by incubating the 
spleen cells in vitro with 5~Cr-labeled tumor cells and measuring the amount of 
released radioactivity. The results (Table I) demonstrate that 5~Cr was eluted 
into the medium during the incubation period and that the extent of the release 
of 51Cr was specific for the tumor used  for immunization. When labeled tumor 
TABLE I 
Cytotoxic Effects of Spleen Cells on Tumor Cells In Vitro 
Spleen  cells* 
Extent of 51Cr release from labeled  tumor cells~; 
EL4  P815  SaI 
%  %  % 
C57BL/6  9  anti-P815  19.5  4-  0,4§  40.5  4-  2.3  NT H 
C57BL/6  9  anti-SaI  15.4  4-  1.2  NT  35.7  4-  0.3 
BALB/c c~ anti-EL4  63.2  ±  1.8  19.6  4-  1.0  7.5  4-  0.8 
NormalC57BL/6  9  9.3  ±  0.7  15.3  ±  1.8  6.7  ±  1.6 
Normal BALB/c c~  11.6  4-  1.4  16.8  4-  2.8  8.1  4-  2.1 
None  12.1  4-  2.7  16.2  4-  1.2  10.9  4-  0.9 
* Immune spleen cells: BALB/c anti-EL4, C57BL/6  9  anti-SaI, and C57BL/6  9  anti- 
P815 cells were prepared from mice that had been injected 11 days previously with 3 X  l0  T 
cells of the appropriate tumor. Normal spleen cells were from noninjected animals. 
Extent of 51Cr released from the labeled tumor cells was determined after 4 hr of incuba- 
tion with the spleen cells by division of the amount of the radioactivity that was released into 
the medium by the total radioactivity. 
§ All figures correspond  to the mean of four replicates 4- relative standard deviation from 
the mean. 
]] NT, not tested. 
cells were incubated with normal spleen cells, the amount of 51Cr released was 
very similar to that obtained when no spleen cells were added. It can also be 
seen  that  the  relative  standard  deviation  from  the  mean  between  replicate 
cultures was small (below 3 %). 
The release of 51Cr from labeled cells has been considered as an expression of 
cellular damage (4,  13,  16). Hence, hereafter, the expression per cent lysis (see 
the Materials and Methods section) rather than per cent 51Cr released is used 
to describe the extent of cytotoxicity for labeled tumor cells. 
Effects of Absorption of Sensitized Spleen Cells with Fibroblast  Monolayers on 
the Subsequent L ysis of Tumor Cells.--The lyric capacity of sensitized spleen cells 
previously  incubated  on  fibroblast monolayers  and  subsequently  harvested 
from the medium (nonadherent cells) has been studied utilizing the above three 
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Spleen cellsof BALB/c cP anti-EL4, C57BL/6  ~  anti-P815, and C57BL/6  9 
anti-SaI were prepared. 60 )<  106 sensitized spleen cells were incubated in vitro 
on fibroblast monolayers of various strains of mice. At the end of the incubation 
period,  the  nonadherent  spleen  cells  were harvested  and  assayed in vitro for 
their lyric reactivity against labeled tumor cells. The results obtained are shown 
in Tables II and III and in Fig.  1. From Table II, it is evident that the non- 
TABLE II 
Lysis of EL4 Cells by Nonadherenl BALB/c Anti-EL4 Spleen Cells 
Exp.  No.  Absorption  with  Lysis I  Decrease][ 
%  % 
1" 
2~ 
3§ 
C57BL/6J  12.9  67.7 
BALB/cJ  36.2  9.5 
DBA/2J  36.0  10.0 
Empty plates  40.0  0 
No absorption  41.9  --4.7 
C57BL/6J  8.3  81.7 
BALB/cJ  42.7  5.9 
DBA/2J  40.3  11.2 
Empty plates  45.4  0 
C57BL/6J  5.4  89.4 
A/J  58.3  -  14.0 
CBA/J  44.7  12.5 
Human  59.0  -- 15.4 
BALB/cJ  47.9  6.2 
DBA/2J  50.1  1.9 
Empty plates  51.1  0 
* Spleen cells were absorbed for 3 hr with  fibroblast monolayers. Then the nonadherent 
cells were harvested  and mixed with "51Cr-labeled EL4 cells and the extent of lysis was deter- 
mined after 4 hr of incubation. 
Absorption for 3.5 hr, lysis for 4 hr. 
§ Absorption for 3.75 hr, lysis for 5 hr. 
II See Materials and Methods for assessment and calculations. 
adherent spleen cells of Balb/c O  anti-EL4 were only slightly cytotoxic to EL4 
cells when they were harvested from C57BL/6 fibroblast monolayers (syngeneic 
with EL4), whereas, BALB/c anti-EL4 spleen cells, harvested after incubation 
on third-party monolayers or empty plates,  were fully cytotoxic to the tumor 
cells. Similar results were obtained with C57BL/6 anti-P815 spleen cells (Table 
III) which, after absorption with DBA/2 or BALB/c fibroblasts  (both H-2d), 
were less cytotoxic than those spleen cells that had been absorbed with C57BL/6 
(H-2 b)  fibroblast  monolayers.  Nevertheless,  absorption  with  C57BL/6  fibro- 
blasts produced a partial decrease in the lytic effect when compared with spleen 
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effect was obtained also with the third tumor, SaI (Fig.  1), in which absorption 
of C57BL/6  9  anti-SaI  spleen  cells for 3  hr  with  A/J fibroblasts  (syngeneic 
with SaI) specifically diminished  the subsequent  killing of the tumor cells. On 
the other hand,  absorption of the sensitized spleen cells with CBA or C57BL/6 
fibroblast monolayers or with empty plates left a  population  of cells capable of 
lysing SaI target cells. 
Basis for the In Vitro Elimination of Specifically Sensitized Spleen Cells.--Two 
TABLE  III 
Lysis of P815 Cells by Nonadherent C57BL/6 Anti-PSI5 Spleen Cells 
Exp. No.  Absorption by  Lysisl[  Decreasell 
1" 
2~ 
3§ 
%  % 
DBA/2J  4.2  79.6 
BALB/cJ  2.0  90.3 
C57BL/6J  13.0  36.9 
Empty plates  20.6  0 
No absorption  19.9  3.3 
DBA/2J  4.4  85.5 
BALB/cJ  2.4  92.9 
C57BL/6J  19.6  35.5 
Empty plates  30.4  0 
DBA/2J  9.1  62.3 
C57BL/6J  15.6  35.5 
Empty plates  24.2  0 
* Spleen cells were absorbed for 3 hr with fibroblast monolayers,  then the nonadherent 
cells were mixed with 51Cr-labeled P815 cells and the extent of lysis determined  after 4 hr of 
incubation. 
Absorption  for 3.5 hr, lysis for 5 hr. 
§ Absorption  for 4 hr, lysis for 4 hr. 
I[ See Materials and Methods for the assessment and calculations. 
possibilities were considered to explain the diminution of the observed extent of 
lysis  obtained  with  the  nonadherent  spleen  cells.  The first  and  most obvious 
possibility was that specifically sensitized killing cells were selectively adsorbed 
onto the monolayer fibroblasts and remained adherent.  The second possibility 
was that sensitized spleen cells were selectively destroyed during the incubation 
period. To support the first hypothesis, it was necessary to recover the adherent 
cells and to demonstrate their capacity to lyse target cells. Recovery of adherent 
cells  was  accomplished  by  trypsinization  of  monolayers,  together  with  the 
adsorbed cells, followed by the separation of the resultant cell suspension on a 
discontinuous  albumin gradient. 
BALB/c c? anti-EL4 spleen cells were preincubated on C57BL/6 and on A/J 
fibroblast monolayers and in empty plates.  After 3 hr of incubation,  the non- 978  IN  VITRO STUDIES ON  TRANSPLANTATION IMMUNITY 
adherent  cells were  removed  and  the  remaining adherent  lymphoid cells,  to- 
gether with the monohtyer fibroblasts, were trypsinized (trypsin 0.25 %) for  10 
rain to obtain a single cell suspension. The three types of cell suspensions, those 
zoi 
Emply Ptotes 
o~  50  BLI6 
40i 
~..  50 
0  I  2  3  4 
TIME OFINCUBATION {M) 
Fro. 1.  Time course of the lysis of SaI cells by nonadherent C57BL/6  9  anti-SaI spleen 
cells.  SlCr-labeled SaI cells were incubated with C57BL/6  9  anti-SaI spleen cells previously 
absorbed with A  (©--©), CBA (A--A), or C57BL/6  (0--0)  fibroblast monolayers or on 
empty plates (m-n). Each point is the mean of three replicates. 
TABLE  IV 
Recovery of BALB/c Anti-EL4 Spleen Cells on Albumin Gradients 
Cells for 
separation 
Extent of lysis of EL4 cells by ceils harvested from 
albumin density interfaces (in per cent BSA) 
17/20  20/25  25/32 
%*  %  % 
Adherent* (to C57BL/6 fibroblasts)  14.6 §  44.31[  36.1 ¶ 
Adherent* (to A fibroblasts)  7.3  14.8  17.1 
Nonadherent (to C57BL/6 flbroblasts)  2.1  13.8  16.8 
Nonadherent (to A flbroblasts)  2.7  63.4  54.3 
Nonadherent (to empty plates)  0.7  85.3  70.9 
* Adherent cells  (lymphoid cells and fibroblasts) were harvested by trypsinization for  10 
min (trypsin 0.25%). 
:~ Per cent lysis of 51Cr-labeled EL4 cells was  determined after 5 hr of incubation with 
the fractionated spleen cells. 
§ 35O-/o fibroblasts. 
[[ 5% fibroblasts. 
¶  <1% fibroblasts. 
nonadherent to empty plates, those nonadherent to C57BL/6  and A/J  mono- 
layers, and the cells adherent to the fibroblasts (with the latter included), were 
layered on individual discontinuous albumin gradients and fractionated.  The GIDEON BERKE AND  RAPHAEL H.  LEVEY  979 
cells from the various fractions were collected, counted,  and assayed for their 
cytolytic activity against 51Cr-labeled EL4 cells. The results (Table IV)  show 
that it was possible both to recover the reactive cells from the syngeneic fibro- 
blasts  (C57BL/6)  and  to  demonstrate  their cytolytic capacity. On  the  other 
hand,  cells recovered from the  allogeneic strain A/J  fibroblasts did not show 
significant reactivity. 
It is clear from Table IV that the procedure employed for the fractionation of 
the cells did not confer lyric reactivity on the adherent lymphoid cells since the 
TABLE V 
Effect of Nonadherent BALB/c Anti-EL4 Spleen Cells on the Growth of EL4  Tumor in B6AFI 
Mice* 
Fibroblast 
for 
absorption 
C57BL/6 
A 
CBA 
No. of 
spleen 
cells 
injected 
(X lo-6) 
6.65 
3.32 
1.61 
6.65 
3.32 
1.61 
6.65 
3.32 
1.61 
1.0§ 
1.7 
1.6 
-I 
1.8 
3.1 
Average tumor diameter at time in days~ 
7  9  11  [  14  16  18 
3.8 
5.7 
5.1 
1.7 
6.5 
7.8 
5.3 
8.0 
7.6 
1.1 
4.1 
4.2 
6.7 
10.4 
8.7 
10.3 
10.7 
4.0 
7.9 
4.8 
9.6 
13.4 
m,n 
11.8 
14.5 
14.0 
5.8 
11.0 
2.6 
7.4 
14.3 
16.7 
14.8 
16.0 
18.3 
6.8 
14.4 
4.3 
10.8 
17.8 
20.3 
16.9 
19.2 
20.0 
8.7 
17.8 
6.4 
14.1 
20.5 
21.8 
20  I  23 
19.4 
22.8 
23.3 
9.9 
20.8 
8.4 
15.4 
22.6 
23.2 
22.4 
24.4 
24.6 
15.9 
23.2 
10.9 
17.2 
23.7 
24.5 
* Mixtures of nonadherent spleen ceils together with 665  X  103 EL4 cells were  rejected 
into B6AF1 9  mice. 
:~ See Materials and Methods for determination. 
§ Each figure is the mean of tumor measurements  for four animals. 
il No measureable  tumor. 
cells which  were  nonadherent  to  C57BL/6  fibroblasts remained  nonreactive 
after the fractionation. As can also be seen, the fractionation procedure was not 
damaging because the cells that were nonadherent to A/J fibroblasts apparently 
retained reactivity after fractionation. 
Effects of Absorption of Sensitized Spleen Cells on Fibroblast Monolayers on the 
Growth of Tumor Cells In Vivo.--As has been described above, sensitized spleen 
cells were  specifically depleted  of  their  in  vitro  cytolytic reactivity against 
tumor cells by preincubation on fibroblast monolayers syngeneic with the tumor 
donor. To demonstrate in vivo the efficacy of the selective elimination of the 
reactive cells in vitro, a modified in vivo tumor neutralization assay was utilized. 980  IN  VITRO  STUDIES  ON  TRANSPLANTATION  I.~IMUNITY 
BALB/c  cP  anti-EL4  spleen cells were preincubated for 3 hr on fibroblast 
monolayers  of  C57BL/6,  A/J,  and  CBA.  The  nonadherent  cells  were  then 
harvested, mixed with EL4 cells,  injected into B6AF~ mice, and the growth of 
the tumors was followed. The data  (Table V) show that the spleen cells that 
had  been absorbed with  C57BL/6 fibroblasts  (syngeneic with  EL4)  failed to 
neutralize the tumor  whereas, tile same cells adsorbed with A/J or CBA fibro- 
blast monolayers were more efficient in the inhibition of tumor growth in vivo. 
The same type of approach also was utilized for the SaI system. C57BL/6  9 
anti-SaI spleen cells were preincubated in vitro for 3 hr on C57BL/6 and A/J 
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FIG.  2.  Effects of nonadherent C57BL/6  9  anti-SaI  spleen cells on  the growth of  SaI 
tumor cells in B6AFI  9  mice. C57BL/6  9  anti-SaI spleen cells were preincubated on fibroblast 
monolayers  of C57BL/6 (©--O), A ([3  [3),  or on empty plates (A--A).The nonadherent 
cells were harvested and mixed with normal C57BL/6 spleen cells in the various proportions 
shown, and 3 X  106 immune and nonimmune spleen cells, together with 1 X  106 SaI cells, 
were injected. Each point is the average tumor measurement for four animals. 
fibroblast monolayers, and in empty dishes. The nonadherent spleen cells were 
then harvested and mixed with SaI tumor cells together with normal C57BL/6 
spleen  cells,  and  the  mixture  was  injected  subcutaneously  into  susceptible 
B6AF1  mice.  The growth  of the  tumor was followed with  time.  The  results 
(Fig. 2) demonstrate that C57BL/6  9  anti-SaI spleen cells which were absorbed 
with A/J fibroblasts failed to neutralize  the  tumor  at  all irmnune spleen cell 
doses  tested,  although  a  certain  degree  of  suppression  was  obtained  when 
3 X  l06 cells were injected. On the other hand, 1.5 X  106 or 3 X  l0 s nonadherent 
C57BL/6  9  anti-SaI spleen cells harvested from C57BL/6  fibroblast  mono- 
layers neutralized  the SaI tumor  (Figs.  2 C  and D); however, the tumor did 
grow when only 0.75  X  10  ~ nonadherent spleen cells were injected (Fig.  2 B). 
C57BL/6  9  anti-SaI spleen cells that did not adhere to empty plastic Petri GIDEON  BERKE  AND  RAPHAEL  H.  LEVEY  981 
dishes were capable of neutralizing the tumor in the three different concentra- 
tions used. From Fig. 2 it is also clear that normal C57BL/6 spleen cells were 
ineffective in retarding tumor growth. 
In Vivo Ejects of Recovered Adherent Cells.--It has been demonstrated (Table 
IV) that the specifically adherent cells recovered from the fibroblast monolayers 
retained their cytotoxic potential against tumor cells in vitro. Table VI extends 
these observations to an in vitro-in  vivo system. C57BL/6  q  anti-SaI spleen 
cells were absorbed on fibroblast monolayers of A/J and  CBA  and in empty 
TABLE VI 
SaI Tumor Growth in B6AFx ~  Mice: Effect of Recovered Adherent Cells* 
Average tumor diameter at time in days~ 
Spleen cells 
4  8  11  13  16  18  22  24  27  29 
Nonadberent  to 
A fibroblasts 
Recovered from 
A fibroblasts 
Nonadherent  to 
CBAfibro- 
blasts 
7.7  13.9  16.4  18.8  18.9  19.1  22.2  23.2  28.4  28.7 
(6/6)§  (6/6)  (6/6)  (6/6)  (6/6)  (6/6)  (4/4)  (3/3)  (2/2)  (1/1) 
11  --  --  7.2  9.0  8.7  10.0  8.4  8.2  7.7 
(1/6)  (1/6)  (I/6)  (1/6)  (1/6)  (1/6)  (2/6) 
6.3  9.0  10.0  10.4  10.9  10.3  13.5  15.7  16.8  17.5 
(1/6)  (1/6)  (2/6)  (2/6)  (2/6)  (2/6)  (2/6)  (2/6)  (2/6)  (2/6) 
Recovered from  --  11.2  13.8  14.9  16.0  16.1  i7.8  17.9  21.2  23.7 
CBA fibro-  (3/6)  (4/6)  (4/6)  (4/6)  (4/6)  (5/6)  (5/6)  (5/6)  (5/6) 
blasts 
Nonadherent  to  --  --  --  7.2  9.2  10.9  14.4  16.0  13.1  18.0 
plastic dishes  (1/6)  (1/6)  (2/6)  (2/6)  (2/6)  (2/6)  (2/6) 
* 1.5 X  106  C57BL/6  anti-SaI spleen cells were injected together with 1 X  106 SaI cells,  subcutaneously  into 
B6AF~  Q  mice. 
See Materials and Methods for determination. 
§ Number of mice having tumors per number of mice observed. 
II No  measurable  tumor. 
plates for 3  hr.  The nonadherent  cells were harvested  and kept at  4°C.  The 
adherent cells together with the fibroblasts were trypsinized to form a  mono- 
dispersed cell suspension and fractionated on a discontinuous albumin gradient, 
as described above. The cells from the lower two gradient  fractions were com- 
bined,  and these  and the nonadherent  cells were then  separately mixed with 
1 X  106 SaI tumor cells and injected into six panels of mice. The tumor growth 
and mortality were observed. The data (Table VI) show that cells nonadherent 
to a monolayer syngeneic with the tumor cells (A/J strain) were less effective 
in retarding tumor growth than those absorbed on an allogeneic (CBA) mono- 
layer or  in  empty plates.  Conversely, recovery of specifically adherent  cells 
yielded those that were efficient in the inhibition of the growth of the tumor. 
In  the  group of mice treated  with  cells  recovered from the  A/J  monolayer, 
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DISCUSSION 
In this paper experiments are presented which show that the preincubation of 
mouse  spleen  cells  sensitized  against  tmnor  allografls  on  mouse  fibroblasts, 
syngeneic with the tumor donor, depletes the immunoreactive cell population. 
Two different procedures were used to demonstrate that the nonadherent cells 
were not only less effective in retarding tumor growth in vivo, but also markedly 
inefficient in lysing tmnor cells in vitro. Furthermore, the adsorbed reactive cells 
that  were recovered were specifically efficient in  inhibiting  tmnor growth  in 
vivo and in killing target tumor cells in vitro. 
The results  which  indicate  that  preincubated  cells were  depleted  of their 
cytolytic effects against tumor cells in vitro are in good agreement with findings 
reported recently by Brondz and  associates  (9,  10),  although in a  few cases 
presented here,  "all or none" effects for the diminution  of the in vitro lyric 
reactivitv of preincubated sensitized spleen cells have not been achieved. How- 
ever,  it  should  be  noted that  these  experiments employed different tumors, 
different cells and methods for the absorption, and most important, a different 
method for the assessment of the cytolytic effect. On the other hand, the find- 
ings in those experiments which demonstrate a diminution in the capacity of 
preincubated sensitized spleen cells to neutralize the growth of tumor cells in 
vivo appear to be unique. 
Recently (4-7,  11),  it has been shown that  sensitized lymphoid cells from 
animals which had undergone graft rejection were capable of in vitro destruc- 
tion of cells from the same strain as the graft donor. Those findings have sub- 
stantiated,  at least circumstantially, the concept that the bTaphoid cell (and 
other cells  as well)  are actually capable of exerting a  cytotoxic effect against 
grafted cells in vivo. The experiments that have been reported in this paper 
might supply further evidence for the suggestion that the destruction of target 
cells in vitro by sensitized lymphoid cells is truly representative of the mode of 
destruction of grafted cells in vivo, for the data represent parallel in vitro and 
in vivo evidence for the diminution of the  capacity  of preincubated  cells  to 
destroy target cells in vitro and to neutralize tumor cells in vivo. However, this 
also is only circumstantial evidence and final proof will rest on the demonstra- 
tion of the performance of these two effects by the same cell rather than by 
populations of cells. The recovery of the specifically adherent lymphoid cells by 
albumin density gradient separations, together with the subsequent demonstra- 
tion that the recovered cells were reactive in the destruction of the tumor cells 
in vitro and in the neutralization of tumor cells in vivo, provides a rationale for 
the assumption that the same lymphoid populations mediate the two effects. 
Several reports have recently described the specific elimination of immuno- 
reactive lymphoid  cell  populations.  Zoschke  and  Bach  (17)  reported such  a 
deletion bv antigen-bromodeoxyuridine-light manipulations. Rich et al? have 
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successfully used  this procedure in  a  mixed lymphocyte reaction and in  the 
graft-vs.-host reaction in rats. Salmon et al.  (18)  were able to accomplish the 
deletion of lymphoid cell populations that are otherwise capable of responding 
to human transplantation antigens by selective cell killing with tritiated thymi- 
dine. The specific absorption of antigen-reactive cells by antigen-coated inert 
material has been successfully used by Wigzel and Andersson (19) for the pro- 
duction of lymphoid cell populations  specifically deprived of immunological 
reactivity and has  allowed  a  detailed analysis of antigen-reactive cell popu- 
lations. 
The  data  recorded  here  and  elsewhere  (9)  indicate  that  another  general 
method may be available in transplantation biology for the removal and re- 
covery of sensitized l~anphoid cell populations. Furthermore, these experiments 
show  that  lymphoid cell populations sensitized  against  tumor  allografts  are 
subsequently able to recognize antigenic determinants present on embryo fibro- 
blasts.  Therefore, absorption of these lymphoid cell populations may yield a 
useful method to recover cells active in tumor immunity. 
These data and that of other experiments  4 justify the expectation that under 
appropriate conditions it may be possible to selectively delete in vitro unwanted 
lymphoid cells from lymphoid and bone marrow grafts in vivo. 
SUMMARY 
Mouse lymphoid cells, sensitized against tumor allografts, can be deprived of 
the immunoreactive cells by in vitro absorption with specific fibroblast mono- 
layers. Populations of lymphocytes so depleted are less  effective in retarding 
tumor growth in vivo and in lysing tumor cells in vitro. Moreover, the adsorbed 
immunoreactive cells can be recovered specifically and are subsequently efficient 
in inhibiting tumor growth in vivo and in killing tumor cells in vitro. 
Further  evidence  is  presented  for  the  suggestion  that  the  destruction  of 
target cells in vitro by sensitized lymphoid cells is truly representative of the 
mode of destruction of grafted cells in vivo. 
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